Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment

HF van Thuijl, T Mazor, BE Johnson, SD Fouse… - Acta …, 2015 - Springer
Temozolomide (TMZ) increases the overall survival of patients with glioblastoma (GBM), but
its role in the clinical management of diffuse low-grade gliomas (LGG) is still being defined …
被引用次数：178 相关文章

Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment

HF van Thuijl, T Mazor, BE Johnson… - Acta …, 2015 - ohsu.elsevierpure.com
Temozolomide (TMZ) increases the overall survival of patients with glioblastoma (GBM), but
its role in the clinical management of diffuse low-grade gliomas (LGG) is still being defined …

Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.

H Thuijl, T Mazor, B Johnson, S Fouse… - Acta …, 2015 - search.ebscohost.com
Temozolomide (TMZ) increases the overall survival of patients with glioblastoma (GBM), but
its role in the clinical management of diffuse low-grade gliomas (LGG) is still being defined …

Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment

HF van Thuijl, T Mazor, BE Johnson… - Acta …, 2015 - search.proquest.com
Temozolomide (TMZ) increases the overall survival of patients with glioblastoma (GBM), but
its role in the clinical management of diffuse low-grade gliomas (LGG) is still being defined …

Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment

HF van Thuijl, T Mazor… - Acta …, 2015 - researchinformation.amsterdamumc …
Temozolomide (TMZ) increases the overall survival of patients with glioblastoma (GBM), but
its role in the clinical management of diffuse low-grade gliomas (LGG) is still being defined …

Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment

HF van Thuijl, T Mazor, BE Johnson, SD Fouse… - Acta …, 2015 - repub.eur.nl
Temozolomide (TMZ) increases the overall survival of patients with glioblastoma (GBM), but
its role in the clinical management of diffuse low-grade gliomas (LGG) is still being defined …

Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment

HF van Thuijl, T Mazor, BE Johnson… - Acta …, 2015 - pubmed.ncbi.nlm.nih.gov
Temozolomide (TMZ) increases the overall survival of patients with glioblastoma (GBM), but
its role in the clinical management of diffuse low-grade gliomas (LGG) is still being defined …
[PDF] academia.edu

[PDF][PDF] Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment

Acta Neuropathol, 2015 - academia.edu
Temozolomide (TMZ) increases the overall survival of patients with glioblastoma (GBM), but
its role in the clinical management of diffuse low-grade gliomas (LGG) is still being defined …

Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.

HF van Thuijl, T Mazor, BE Johnson… - Acta …, 2015 - europepmc.org
Temozolomide (TMZ) increases the overall survival of patients with glioblastoma (GBM), but
its role in the clinical management of diffuse low-grade gliomas (LGG) is still being defined …
[HTML] nih.gov

[HTML][HTML] Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment

HF van Thuijl, T Mazor, BE Johnson… - Acta …, 2015 - ncbi.nlm.nih.gov
Temozolomide (TMZ) increases the overall survival of patients with glioblastoma (GBM), but
its role in the clinical management of diffuse low-grade gliomas (LGG) is still being defined …